-
-
-
-
-
-
-
Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update
-
-
-
-
-
-
-
DA Davidson Reiterates Buy Rating on The Lovesac Co. (LOVE)
-
-
-
-
-
-
-
The Lovesac Company Announces Fourth Quarter and Fiscal 2025 Conference Call Date
-
-
-
-
-
-
-
Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market
-
-
-
-
-
-
-
The Lovesac Company Announces First Quarter Conference Call Date
-
-
-
-
-
-
-
Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues
-
-
-
-
-
-
-
The Lovesac Company Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

